Publications by authors named "Jon-Magnus Tangen"

Claim this Profile
N
NETs analysed by novel calprotectin-based assays in blood donors and patients with multiple myeloma or rheumatoid arthritis: A pilot study.
Magne Kristoffer Fagerhol, Egil Johnson, Jon-Magnus Tangen, Ivana Hollan, Mohammad Reza Mirlashari

Scand J Immunol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor, Anti-Inflammatory and Antiallergic Effects of Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, and : A Review of Preclinical and Clinical Studies.
Geir Hetland, Jon-Magnus Tangen, Faiza Mahmood, Mohammad Reza Mirlashari, Lise Sofie Haug Nissen-Meyer

Nutrients· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis.
Jon-Magnus Tangen, Geir Erland Tjønnfjord, Nina Gulbrandsen, Tobias Gedde-Dahl, Espen Stormorken

BMC Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Murill Based Mushroom Extract, Andosan™.
Jon-Magnus Tangen, Toril Holien, Mohammad Reza Mirlashari, Kristine Misund, Geir Hetland

Biomed Res Int· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer, epidemiology and nuclear accidents.
Jon-Magnus Tangen

Tidsskr Nor Laegeforen· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study.
Jon-Magnus Tangen, Anne Tierens, Jo Caers, Marilene Binsfeld, Ole Kristoffer Olstad

Biomed Res Int· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperleukocytosis.
Çiğdem Akalın Akkök, Astrid Bergrem, Jon Magnus Tangen

Tidsskr Nor Laegeforen· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute radiation injuries.
Jon-Magnus Tangen, Alicja Jaworska

Tidsskr Nor Laegeforen· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy with autologous stem cell support for lymphoma--from experimental to standard treatment.
Knut Bjøro Smeland, Cecilie E Kiserud, Grete F Lauritzsen, Alexander Fosså, Jens Hammerstrøm, Jon Magnus Tangen

Tidsskr Nor Laegeforen· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Fukushima accident--health consequences.
Jon-Magnus Tangen, Alicja Jaworska, Håkan Mattsson

Tidsskr Nor Laegeforen· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Survival in adults with acute lymphoblastic leukaemia].
Jon-Magnus Tangen, Yngvar Fløisand, Einar Haukås, Inger Anne Naess, Tove Skjelbakken

Tidsskr Nor Laegeforen· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia.
Per Ole Iversen, Ekaterina Ukrainchenko, Boris Afanasyev, Kristin Hulbekkmo, Amal Choukah, Jon-Magnus Tangen

Leuk Lymphoma· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[High-dose treatment of systemic AL-amyloidosis with autologous stem cell support].
Fredrik Hellem Schjesvold, Malvin Sjo, Jon-Magnus Tangen, Jens Hammerstrøm, Lorentz Brinch

Tidsskr Nor Laegeforen· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Survival in adults with acute myelogenous leukemia].
Jon-Magnus Tangen, Yngvar Fløisand, Jenny Foss-Abrahamsen, Einar Haukås, Inger Anne Naess

Tidsskr Nor Laegeforen· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
Ulf-Henrik Mellqvist, Stig Lenhoff, Hans E Johnsen, Martin Hjorth, Erik Holmberg, Jon Magnus Tangen

Cancer· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.
Michael Grövdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Jon Magnus Tangen

Clin Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.
Dag Torfoss, E Arne Høiby, Jon Magnus Tangen, Harald Holte, Kåre Bø

J Antimicrob Chemother· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.
Stig Lenhoff, Martin Hjorth, Jan Westin, Lorentz Brinch, Bengt Bäckström, Jon Magnus Tangen

Br J Haematol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Per Anders Broliden, Inger-Marie Dahl, Robert Hast, Bertil Johansson, Eeva Juvonen, Jon-Magnus Tangen

Haematologica· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.
Katrin Sigurdardottir, Asbjørn Digranes, Stig Harthug, Ingerid Nesthus, Jon-Magnus Tangen

Scand J Infect Dis· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia.
Astrid Gruber, Magnus Björkholm, Lorentz Brinch, Stein Evensen, Bengt Gustavsson, Jon Magnus Tangen

Leuk Res· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
Eva Hellström-Lindberg, Nina Gulbrandsen, Greger Lindberg, Tomas Ahlgren, Inger Marie S Dahl, Jon Magnus Tangen

Br J Haematol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis